*SCALPSWINGSTRADDLE*

[Zephyr]

Gapping down In reaction to disappointing earnings/guidance: GEF -10.2%, VEEV -8.6%, PSUN -7%, QADA -5.2%, GCO -4.1%, FRO -3.9%, NBG -3.7%, SPLK -2.3%, DECK -2.2%, PLUS -1.8% Other news: GEVO -3.6% (pulling back after late day move yesterday), CYBR -3.1% (files a registration statement for a follow-on offering of common stock), YGE -2.9% (acknowledges awareness of a class action lawsuit against the company, and after reviewing the claims believes they are without merit), SYT -2.1% (cont volatility surround M&A chatter), MEET -2% (disclosed that Richard Friedman resigned as Chief Technology Officer effective as of July 3, 2015), SD -1.7% (priced upsized offering of offering of $1.25 bln of 8.75% senior secured notes due 2020),, AZN -1.3% (AstraZeneca and Eli Lilly (LLY) enter into a clinical trial collaboration to evaluate the safety and preliminary efficacy of MEDI4736 in combination with ramucirumab) Analyst comments: HIMX -2% (downgraded to Sell from Neutral at Chardan Capital Markets), ARCB -1.9% (downgraded to Underperform from Neutral at BofA/Merrill), URI -1% (downgraded to Underperform from Neutral at BofA/Merrill), ALDW -0.9% (reinstated with an Underweight at Barclays), POT -0.7% (downgraded to Hold from Buy at TD Securities)